TRANSMIT ENT (01326) received resumption guidance from the Hong Kong Stock Exchange.

TRANSMIT ENT (01326) issued an announcement that on December 24, 2025, the company received the following resumption guidance from the Hong Kong Stock Exchange: (i) to publish all unpublished financial performance in accordance with the listing rules and address any audit modification opinions; (ii) to conduct an independent internal control review and demonstrate that the company has appropriate internal controls and procedures to comply with obligations under the listing rules; (iii) to demonstrate compliance with listing rule 13.24; (iv) to disclose all important information to the market for shareholders and investors to assess the company's condition.